Related references
Note: Only part of the references are listed.The Role of Serum Calprotectin in Defining Disease Outcomes in Non-Systemic Juvenile Idiopathic Arthritis: A Pilot Study
Debora Mariarita d'Angelo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
High BM plasma S100A8/A9 is associated with a perturbed microenvironment and poor prognosis in myelodysplastic syndromes
Yu-Hung Wang et al.
BLOOD ADVANCES (2023)
S100A8/A9 Is a Marker for the Release of Neutrophil Extracellular Traps and Induces Neutrophil Activation
Evelien G. G. Sprenkeler et al.
CELLS (2022)
C/EBPd-induced epigenetic changes control the dynamic gene transcription of S100a8 and S100a9
Saskia-Larissa Jauch-Speer et al.
ELIFE (2022)
Bone marrow stroma cells promote induction of a chemoresistant and prognostic unfavorable S100A8/A9high AML cell subset
Martin Boettcher et al.
BLOOD ADVANCES (2022)
Plasma Calprotectin Levels Associate with Suspected Metabolic-Associated Fatty Liver Disease and All-Cause Mortality in the General Population
Arno R. R. Bourgonje et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis
Nils B. Leimkuhler et al.
CELL STEM CELL (2021)
S100A8/S100A9 cytokine acts as a transcriptional coactivator during breast cellular transformation
Ruisheng Song et al.
SCIENCE ADVANCES (2021)
Serum calprotectin (S100A8/A9) levels as a new potential biomarker of treatment response in Hodgkin lymphoma
Seyma Sumnu et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2021)
Using blood calprotectin as a measure of blood neutrophils
Arne Asberg et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2021)
Fecal calprotectin is a useful biomarker for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis in ulcerative colitis patients: a prospective observation study
Nobuhiro Ueno et al.
BMC GASTROENTEROLOGY (2021)
Calprotectin: from biomarker to biological function
Almina Jukic et al.
GUT (2021)
S100A9 Derived From Myeloma Associated Myeloid Cells Promotes TNFSF13B/TNFRSF13B-Dependent Proliferation and Survival of Myeloma Cells
Lingzhang Meng et al.
FRONTIERS IN ONCOLOGY (2021)
Calprotectin, a new biomarker for diagnosis of acute respiratory infections
Aleksandra Havelka et al.
SCIENTIFIC REPORTS (2020)
Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN
Helene F. E. Gleitz et al.
BLOOD (2020)
S100A8 and S100A9 Promote Apoptosis of Chronic Eosinophilic Leukemia Cells
Ji-Sook Lee et al.
FRONTIERS IN IMMUNOLOGY (2020)
Myelodysplastic Syndromes
Mario Cazzola
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Circulating S100A8 and S100A9 protein levels in plasma of patients with acquired aplastic anemia and myelodysplastic syndromes
Valentina Giudice et al.
CYTOKINE (2019)
S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes
Pinyang Cheng et al.
LEUKEMIA (2019)
S100A8 & S100A9: Alarmin mediated inflammation in tendinopathy
Lindsay A. N. Crowe et al.
SCIENTIFIC REPORTS (2019)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
iTRAQ-based quantitative protein expression profiling of biomarkers in childhood B-cell and T-cell acute lymphoblastic leukemia
Runhong Yu et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Serum calprotectin: A circulating biomarker of the inflammatory state in Philadelphia-negative myeloproliferative neoplasms
Ivan Krecak et al.
BLOOD CELLS MOLECULES AND DISEASES (2019)
Inflammation and Cancer
Nitin Singh et al.
ANNALS OF AFRICAN MEDICINE (2019)
The Bone Marrow Microenvironment in Health and Myeloid Malignancy
Marta Galan-Diez et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
S100 Proteins As an Important Regulator of Macrophage Inflammation
Chang Xia et al.
FRONTIERS IN IMMUNOLOGY (2018)
BET Inhibition Suppresses S100A8 and S100A9 Expression in Acute Myeloid Leukemia Cells and Synergises with Daunorubicin in Causing Cell Death
Helen J. S. Stewart et al.
BONE MARROW RESEARCH (2018)
Calprotectin in rheumatic diseases
Francesca Ometto et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2017)
Myeloid-Derived Suppressor Cells
Dmitry I. Gabrilovich
CANCER IMMUNOLOGY RESEARCH (2017)
Regulatory mechanism and functional analysis of S100A9 in acute promyelocytic leukemia cells
Yonglan Zhu et al.
FRONTIERS OF MEDICINE (2017)
Mesenchymal Inflammation Drives Genotoxic Stress in Hematopoietic Stem Cells and Predicts Disease Evolution in Human Pre-leukemia
Noemi A. Zambetti et al.
CELL STEM CELL (2016)
High expression of S100A8 gene is associated with drug resistance to etoposide and poor prognosis in acute myeloid leukemia through influencing the apoptosis pathway
Xiao-yan Yang et al.
ONCOTARGETS AND THERAPY (2016)
S100A9 and ORM1 serve as predictors of therapeutic response and prognostic factors in advanced extranodal NK/T cell lymphoma patients treated with pegaspargase/gemcitabine
Zhiyuan Zhou et al.
SCIENTIFIC REPORTS (2016)
Biomarkers of Inflammation in Inflammatory Bowel Disease
Bruce E. Sands
GASTROENTEROLOGY (2015)
Evolution of the S100 family of calcium sensor proteins
Danna B. Zimmer et al.
CELL CALCIUM (2013)
Functions of S100 Proteins
R. Donato et al.
CURRENT MOLECULAR MEDICINE (2013)
Induction of myelodysplasia by myeloid-derived suppressor cells
Xianghong Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Pro-Inflammatory S100A8 and S100A9 Proteins: Self-Assembly into Multifunctional Native and Amyloid Complexes
Thomas Vogl et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
From genes to drugs: targeted strategies for melanoma
Keith T. Flaherty et al.
NATURE REVIEWS CANCER (2012)
Chronic Immune Stimulation Might Act As a Trigger for the Development of Acute Myeloid Leukemia or Myelodysplastic Syndromes
Sigurdur Y. Kristinsson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients
E. Nicolas et al.
LEUKEMIA (2011)
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Subhra K. Biswas et al.
NATURE IMMUNOLOGY (2010)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells
Pratima Sinha et al.
JOURNAL OF IMMUNOLOGY (2008)
S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway
Saeid Ghavami et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Mrp8 and Mrp14 are endogenous activators of Toll- like receptor 4, promoting lethal, endotoxin-induced shock
Thomas Vogl et al.
NATURE MEDICINE (2007)
Mechanisms of Disease: a 'DAMP' view of inflammatory arthritis
Dirk Foell et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2007)
Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells
Hae-Young Yong et al.
ARCHIVES OF PHARMACAL RESEARCH (2007)
Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity
Nadja Leukert et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Opinion - Profiling early head and neck cancer
KD Hunter et al.
NATURE REVIEWS CANCER (2005)
S100A8 and S100A9 activate MAP kinase and NF-κB signaling pathways and trigger translocation of RAGE in human prostate cancer cells
A Hermani et al.
EXPERIMENTAL CELL RESEARCH (2005)
MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes
T Vogl et al.
BLOOD (2004)
Interleukin-10 influences the expression of MRPS and MRP14 on human dendritic cells
A Kumar et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2003)
Share Paper
